Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 7, 2020; 26(41): 6475-6487
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6475
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6475
Table 1 Baseline characteristics and treatment outcome of the third-look endoscopy group
| TLE group (n = 114) | TLE group (n = 114) | ||
| Age, mean ± SD (yr) | 75.5 ± 0.6 | En-bloc resection, % (n) | 100 (114) |
| Sex | R0 resection, % (n) | 100 (114) | |
| Male, % (n) | 86.0 (98) | Curative resection, % (n) | 90.4 (103) |
| Female, % (n) | 14.0 (16) | Median procedure time (range) | 41.5 (10-180) |
| Location-1 | SLE Hemostasis, % (n) | 68.8 (77) | |
| Upper, % (n) | 18.4 (21) | Forrest classification 1b, % (n) | 10.7 (12) |
| Middle, % (n) | 12.3 (14) | Forrest classification 2a, % (n) | 58.0 (65) |
| Lower, % (n) | 69.3 (79) | TLE Hemostasis, % (n) | 35.7 (40) |
| Location-2 | Forrest classification 1b, % (n) | 10.7 (12) | |
| Anterior wall, % (n) | 8.8 (10) | Forrest classification 2a, % (n) | 25.0 (28) |
| Posterior wall, % (n) | 31.6 (36) | The day of TLE, % (n) | |
| Lesser curvature, % (n) | 40.3 (46) | POD 4 | 29.8 (34) |
| Greater curvature, % (n) | 19.3 (22) | POD 5 | 54.4 (62) |
| Morphology | POD 6 | 14.0 (16) | |
| Protruded, % (n) | 42.9 (49) | Comorbidities | |
| Flat/depressed, % (n) | 57.0 (65) | Hypertension, % (n) | 85.1 (97) |
| Median tumor size (range) | 11.0 (2-70) | Diabetes mellitus, % (n) | 21.9 (25) |
| Median specimen size (range) | 35.0 (18-95) | Hyperlipidemia, % (n) | 54.4 (62) |
| Synchronous occurrence, % (n) | 22.9 (22/96 patients) | Cardiac disease, % (n) | 69.3 (79) |
| Ulcerative findings | Cerebral infarction, % (n) | 24.6 (28) | |
| (+), % (n) | 5.3 (6) | Hemodialysis, % (n) | 3.5 (4) |
| (-) , % (n) | 94.7 (108) | Receiving antithrombotic agents | |
| Depth of invasion | Continue, % (n) | 100 (114) | |
| M/SM1, % (n) | 98.2 (112) | Discontinue, % (n) | 0 (0) |
| SM2-, % (n) | 1.8 (2) | Antithrombotic agents | |
| Pathological finding | Aspirin, % (n) | 43.9 (50) | |
| Differentiated type, % (n) | 95.6 (109) | Thienopyridine, % (n) | 10.5 (12) |
| Undifferentiated type, % (n) | 4.4 (5) | Cilostazol, % (n) | 5.3 (6) |
| lymphovascular infiltration | Warfarin, % (n) | 2.6 (3) | |
| (+), % (n) | 4.4 (5) | DOAC, % (n) | 20.2 (23) |
| (-) , % (n) | 95.6 (109) | Multiple antithrombotic agents, % (n) | 17.5 (20) |
- Citation: Ikeda R, Hirasawa K, Sato C, Ozeki Y, Sawada A, Nishio M, Fukuchi T, Kobayashi R, Makazu M, Taguri M, Maeda S. Third-look endoscopy prevents delayed bleeding after endoscopic submucosal dissection under antithrombotic therapy. World J Gastroenterol 2020; 26(41): 6475-6487
- URL: https://www.wjgnet.com/1007-9327/full/v26/i41/6475.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i41.6475